biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by Sniper007on Feb 21, 2013 5:32pm

139 Views

Post# 21025270

RE: Maybe ....

Sinbob,

I know you're one of the originals here and we are indeed on the same team. Personally, I'm grateful for all that you've contributed.

I agree that there are many BTI investors/readers here who have yet to sign up to SH. I would encourage all of you to do so - it only takes a couple of minutes. If you're invested, or thinking about it, quit sitting on your hands.

Sniper

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario